Nalan Selçuk

9PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)AllergyAstroparticle physics and particle cosmologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
The role of 68Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited 18F-FDG Uptake.

|Dec 09, 2025
Istanbul PSMA PET/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance.

Levent Kabasakal, Kaan Akçay, Alan Nalan Selçuk

|Feb 07, 2025
Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings.

Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay

|Feb 07, 2025
Improved Accuracy and Reliability of PRIMARY Scoring Using Delayed [68Ga] Ga-PSMA PET/CT Imaging.

Kaan Akçay, Gamze Beydağı, Onur Erdem Şahin

|Jul 01, 2024
Revision of the Histopathological Examination Following 68Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis.

Nalan Alan Selçuk, Kaan Akçay, Gamze Beydağı

|Dec 19, 2023
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.

Kaan Akcay, Ali Kibar, Onur Erdem Sahin

Pageof 2

Frequent Collaborators

9 joint publications

Levent Kabasakal

7 joint publications

Kaan Akçay

7 joint publications

Gamze Beydağı

6 joint publications

Türkay Toklu